Team Members

Amanda Smith

Amanda Smith joined Rebus Biosystems as Vice President, Human Resources in March 2022, bringing more than 20 years’ experience in human resources and communications. Most recently, Amanda was Senior Director, Human Resources for Santa Cruz Nutritionals. Amanda began her career in the news media before transitioning to corporate communications at Circuit City, Inc. She moved […]

Read More

Eric Williams

Eric Williams joined Rebus Biosystems as Chief Financial Officer in 2022. He brings over 30 years of cross-functional experience in high tech businesses from start-ups to large scale public companies. Prior to joining Rebus Biosystems, Eric has served as CFO in a variety of high-tech companies including NovalSignal, Evidation Health, Mimosa and Soraa.   In addition, […]

Read More

Tom Willis, Ph.D.

Tom Willis has been an entrepreneur in the genomics industry for the past 15 years during which time he founded and successfully exited two startups in the genomic tools and diagnostic space. After having received his undergraduate and graduate degrees in physics from Yale and Stanford respectively, he directed technology development efforts at the Stanford […]

Read More

Bingqing Zhang

Bingqing Zhang joined Rebus Biosystems in September 2021 as Senior Director, Product Development. Bingqing is a successful R&D leader with years of experience in the life sciences and spatial-omics field specializing in product development journey from conception to commercialization. Prior to joining Rebus, she served as Director of R&D in the Genomics Division of Bio-Techne/Advanced […]

Read More

Viet Truong

Viet has over 28 years in the medical device industry leading Operations in capital equipment, disposable, and implantable medical devices.   Viet has established several production floors from early stages (white space) to commercialization stages for several start-up medical device companies.   Prior to joining Rebus Biosystems, Viet was VP of Operations at AccuVein, a medical device […]

Read More

Ramesh Ramakrishnan

Ramesh Ramakrishnan joined Rebus Biosystems as Senior Vice President of Product Development in October 2021, bringing over 25 years of product development experience in the life science industry.  Most recently, Dr. Ramakrishnan was Senior Vice President of Research & Development at Talis Biomedical, a point of care diagnostic company. Prior to this, he was Senior […]

Read More

Tarif Awad, PhD

Tarif Awad joined Rebus Biosystems as Vice President of Scientific Affairs in 2021, bringing over 20 years of experience in the development and commercialization of multiple genomics platforms, and collaborating with scientists on basic, translational, and clinical applications. Prior to joining Rebus Biosystems, Tarif spent several years with Thermo Fisher Scientific driving strategic partnerships with test makers and global […]

Read More

Danilo Tait, PhD, MBA

Based in Heidelberg Germany, Danilo Tait joined Rebus Biosystems as Vice President Commercial Operations for the EMEA region in 2021. Danilo spent the last 20 years in commercial roles and leadership positions with a variety of life sciences companies including BD Biosciences, Qiagen, and Agilent.  Most recently, Danilo was Director of European Operations at Advanced Analytical Technologies Inc. […]

Read More

Gloria Chui, PhD

Gloria Chui joined Rebus Biosystems as Principal Scientist, Reagent Products in 2021. She brings 25 years of research and development experience in biochemistry, genomics and IVD product development to the company. Gloria is responsible for the development of chemistry and reagent product consumables for the Rebus Esper High Fidelity Assay platforms. Prior to joining Rebus, she was Staff Scientist at Applied Biosystems and Guardant Health leading […]

Read More

Hojin Lee, MS

Hojin Lee joined Rebus Biosystems in 2010 and is now Director of Engineering.  He is responsible for the system and software engineering of Rebus Bio’s imaging system.  Since he joined the company, Hojin has been contributing to improvements in the company’s proprietary SAO technology as well as system automation.  Hojin previously worked at the Samsung Advanced Institute of Technology of Samsung Electronics where […]

Read More

Simone Codeluppi, PhD

Simone Codeluppi joined Rebus Biosystems as Principal Scientist, Bioinformatics in 2021. Prior to that he was an Assistant Professor at the Karolinska Institutet in Stockholm, Sweden. During his time at the Karolinska Institutet he led a team focused on the development and automation of single molecule fluorescence hybridization (smFISH) technologies. Simone earned his PhD in Molecular Pathology from the University of California, San Diego […]

Read More

Neil Kennedy

Neil Kennedy joined Rebus Biosystems as Chief Commercial Officer in January 2021, bringing 25 years commercial experience in the life science industry with a proven track record of developing and commercializing transformational products and services for the basic, translational and clinical research markets. Most recently, Neil was Senior Vice President Commercial Operations at Dovetail Genomics. […]

Read More

Josh Ryu, PhD

Ryu is the co-founder and Chief Technology Officer of Rebus Biosystems.  During his time at MIT, he was one of the original developers of  the company’s core technology, Synthetic Aperture Optics (SAO). Josh co-founded Rebus Biosystems in 2006 and served as the company’s Chief Executive Officer from its founding through 2020 when he took on […]

Read More